Combinations of inhibin with bronchodilators

Abstract

The invention provides medicaments comprising combinations of bronchodilators, glucocorticosteroids and HMG-CoA reductase inhibitors in the treatment of respiratory disorders such as chronic obstructive pulmonary disease (COPD).

Description

technical field [0001] The present invention provides medicaments for the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) comprising combinations of bronchodilators, glucocorticosteroids and HMG-CoA reductase inhibitors. Background technique [0002] The diagnosis and treatment of many diseases focus, for obvious reasons, on the typical criteria and manifestations that are characteristic of a particular disease (thereby distinguishing it from other diseases). Examples are joint-related signs and symptoms in rheumatoid arthritis (RA), and lung function tests in COPD. [0003] But many diseases have significant co-morbidity, and they are often considered "other" diseases because they are not unique to or specific to the primary disease. For example, cardiovascular co-morbidities may often be considered indeterminate and not directly related to primary diseases such as RA or COPD. However, co-morbidities can be as important as regular ma...

AI Technical Summary

Problems solved by technology

[0006] In addition, anti-inflammatory drugs currently developed for the signs and symptoms of specific diseases may not be optimized for the long-term treatment of concurrent systemic inflammation, which is postulated to be the cause of many common pathologies